Doug Sandlinadded this to Technology Unbound3D Bioprinting Scientists 3D-print biological tissue without using scaffoldsnewatlas.com - Ben Coxworth Although it may be hard to believe that there is already an "established" method of doing something such as 3D-printing biological tissue, there does …
Oscar Seguradoadded this to Genomics & Gene Therapy 101Bioinformatics Genome sequencing analysis identifies Epstein–Barr virus subtypes associated with high risk of nasopharyngeal carcinomanature.com - Miao Xu, Youyuan Yao, Hui Chen, Shanshan Zhang, Su-Mei Cao, Zhe Zhang, Bing Luo, Zhiwei Liu, Zilin Li, Tong Xiang, Guiping He, Qi-Sheng Feng, Li-Zhen Chen, Xiang Guo, Wei-Hua Jia, Ming-Yuan Chen, Xiao Zhang, Shang-Hang Xie, Roujun Peng, Ellen T. Chang, Vincent Pedergnana, Lin Feng, Jin-Xin Bei, Rui-Hua Xu, Mu-Sheng Zeng, Weimin Ye, Hans-Olov Adami, Xihong Lin, Weiwei Zhai, Yi-Xin Zeng, Jianjun Liu Epstein, M. A., Achong, B. G. & Barr, Y. M. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1, 702–703 (1964). Epstein, A. Why …
Synthetic Biology How synthetic biology could wipe out humanity -- and how we can stop itted.com - Rob Reid The world-changing promise of synthetic biology and gene editing has a dark side. In this far-seeing talk, author and entrepreneur Rob Reid reviews …
Business Insideradded this to SciencePfizer 3 biotechs that investors should buy next after Pfizer's $11 billion deal for cancer drugmaker Array BioPharmaBusiness Insider - Clarrie Feinstein, Emma CourtGiant pharmaceutical company Pfizer just announced that it is buying the biotech Array BioPharma for $11.4 billion, a major deal that's only the latest example of big drugmakers snapping up cancer-focused
Gene Therapy Jesse Gelsinger’s death and the risks of gene therapywhyy.org About 30 million Americans have this allergy noted in their medical records. That means the most commonly prescribed antibiotics are off-limits. The …
Stem Cells Advances in stem cell research and therapeutic developmentnature.com - Michele De Luca, Alessandro Aiuti, Giulio Cossu, Malin Parmar, Graziella Pellegrini, Pamela Gehron Robey Sipp, D. et al. Marketing of unproven stem cell-based interventions: a call to action. Sci. Transl. Med. 9, eaag0426 (2017). Thomas, E. D., Lochte, H. …
Axiosadded this to AxiosBig Pharma Cancer treatments are one of the most in-demand Big Pharma assetsAxios - Bob Herman Pfizer's $11.4 billion takeover of Array BioPharma highlights how eager industry titans are to commercialize cancer medications, making cancer the …
Reuters UKadded this to BusinessPersonalized Medicine Roche wins Japan approval for personalised cancer drug RozlytrekReuters - by John MillerFILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann ZURICH (Reuters) - Swiss drugmaker Roche on Tuesday won approval
Business Insideradded this to ScienceMedicine Biotech CEO Sheila Gujrathi: best advice for doctors leaving medicineBusiness Insider - Emma CourtAfter training to be a physician at places like Stanford and Harvard, that was the case for Dr. Sheila Gujrathi. When speaking with physician colleagues and friends, Gujrathi — now the co-founder and of
FFull Nameadded this to MicrobiomeMicrobiomeQuantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterationsnature.com - Sara Vieira-Silva, João Sabino, Mireia Valles-Colomer, Gwen Falony, Gunter Kathagen, Clara Caenepeel, Isabelle Cleynen, Schalk van der Merwe, Séverine Vermeire, Jeroen Raes Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 …
Audioburstadded this to Audioburst Business NewsPfizer Listen: Pfizer spends $11.4B to buy Array BioPharma for its cancer drugAudioburst - MarketFoolery "Buying a Ray bio pharma in a deal worth nearly eleven and a half billion dollars array bio pharma. And if you're a shareholder congrats stocks up …
Joseph Kiraguadded this to Jj piques Tripura Udaipur first in state to treat waste in natural wayhindustantimes.com - Nikita Bishnoi The process called bioremediation has been introduced in Udaipur city for treating legacy waste — garbage hill accumulated for several years; some of …
Ogdensignadded this to Noster Opusculous Expectation Unity Biotechnology results exceed expectations, but highlight long road ahead for longevity drugsstatnews.com - Matthew Herper • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and …
The New York Timesadded this to OpinionBiology The Seed Industry Favors InnovationThe New York TimesRe “Save Our Food. From the Seed Barons” (Sunday Review, June 9): Chef Dan Barber misses the mark about the changes in the seed industry over the last century. It’s true that crop production across the
Seeking AlphaInvesting Rocket Pharma begins patient dosing in early-stage RP-A501 trialSeeking Alpha - Mamta Mayani Rocket Pharmaceuticals (NASDAQ:RCKT) has commenced patient dosing in Phase 1 clinical trial of RP-A501, the Company’s adeno-associated viral vector …
DNA sequencing US Burden of Disease, LABAs and LAMAs for Asthma, Tumor DNA Sequencing to Guide Cancer Management, and moreama-assn.org - edhub.ama-assn.org Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 10, 2018 issue
DNA Testing Considering a DNA test? Helpful tips before you take the plungemayoclinic.org - By Sharon Rosen The availability of genetic testing has exploded. You hear about it on television, the radio and the internet. Family members are verifying age-old …
BioinformaticsComparative genomics of chytrid fungi reveal insights into the obligate biotrophic and pathogenic lifestyle of Synchytriumnature.com - Bart T. L. H. van de Vossenberg, Sven Warris, Hai D. T. Nguyen, Marga P. E. van Gent-Pelzer, David L. Joly, Henri C. van de Geest, Peter J. M. Bonants, Donna S. Smith, C. André Lévesque, Theo A. J. van der Lee Heckman, D. S. et al. Molecular Evidence for the Early Colonization of Land by Fungi and Plants. Science 293, 1129 (2001). Gleason, F. H., Kagami, M., …
Ars Technicaadded this to Ars TechnicaSynthetic Biology Ars on your lunch break: Let’s talk about the extinction of humanityArs Technica - Rob Reid Synthetic biology sounds great, but the ways in which it could go wrong are legion. Welcome back to Ars on your Lunch Break! It’s been a while since …
e smithadded this to Consumer IssuesFood Grow Faster, Grow Stronger: Speed-Breeding Crops to Feed the FutureThe New York Times - By KNVUL SHEIKHFarmers and plant breeders are in a race against time. The world population is growing rapidly, requiring ever more food, but the amount of cultivable land is limited. Warmer temperatures have extended
AxiosGene Therapy $1.8 million gene therapy will be the 2nd-most expensive drug in the worldAxios - Bob Herman The price of Zynteglo, a new gene therapy made by Bluebird Bio to treat a rare genetic blood disorder, will be almost €1.6 million ($1.8 million) in …
Bio News Servicesadded this to Parkinson's News TodayParkinson's Disease Man-made DNA Molecules May Help Prevent Parkinson’s, Study Findsparkinsonsnewstoday.com - Catarina Silva Osaka University scientists have built short fragments of DNA that can stop the production of abnormal alpha-synuclein protein in the brain — which …
ReutersGene Therapy UniQure NV weighs options including sale: BloombergReuters - Reuters Editorial(Reuters) - Gene therapy company UniQure NV is exploring options including a sale amid interest from other pharmaceutical companies looking to expand in gene therapy, Bloomberg reported on Sunday citing
Investor's Business Dailyadded this to Financial & Business NewsPfizer How Pfizer's $11.4 Billion Takeover Of Array Signals More Mergersinvestors.com - ALLISON GATLIN Dow Jones component Pfizer (PFE) is buying biotech company Array BioPharma (ARRY) in an $11.4 billion deal that reaps the rewards of two approved …
PPeak Bggradded this to Biotech InvestingGene Therapy UniQure considering potential sale - BloombergSeeking Alpha - Carl Surran UniQure (NASDAQ:QURE) +6.8% pre-market following a Bloomberg weekend report that the company is exploring options including a potential sale or …
FlipboardIcon version of the Flipboard logoTechnology Invitae to Acquire Singular Bio to Help Increase Access to Genetic Screening in Early Pregnancyyahoo.com - PR Newswire -- Singular Bio's Technology Designed to Enable High-Quality, Low-Cost Genetic Testing at Scale to Expand Access to Non-Invasive Prenatal Screening -- …
RRick Timmeradded this to BioPharma & MedicineGenes What does personalised medicine mean for you?BBC News - Dr Emma DavenportMedicine has always been personal to some extent - a doctor looks for the best way to help the patient sitting in front of them. But with advances in technology, it is becoming possible to use the most
Gene Therapy Researchers report longest duration of therapeutic gene expression | EurekAlert! Science Newseurekalert.org - www.eurekalert.org New Rochelle, NY, June 14, 2019--A therapeutic gene delivered into the spinal canal of infant rhesus monkeys was still being expressed after nearly 4 …
HHelaineadded this to Odds and EndsDNA sequencingDNA Sequencing Market Overview 2019: Industry Size, Global Share, Technology Trends, Growth Analysis, Competitive Landscape,ReutersGlobal DNA Sequencing Market Research Report: By Type (Workflow Products and Others), By Product (Sequencing Services and Others), By Technology (Semiconductor Sequencing and Others), By Application (Diagnostics
AxiosGene Therapy 2. Drugmakers sue over TV ad ruleAxios None of Congress' proposals to rein in surprise medical bills address ambulances — which are expensive and often aren't covered by insurance. Why it …
